EUVIMEDEUVIMED entdecken
Open Access

A Multiplexed Cas13-Based Assay with Point-of-Care Attributes for Simultaneous COVID-19 Diagnosis and Variant Surveillance

Maturada Patchsung, Aimorn Homchan, Kanokpol Aphicho, Surased Suraritdechachai, Thanyapat Wanitchanon, Archiraya Pattama, Khomkrit Sappakhaw, Piyachat Meesawat, Thanakrit Wongsatit, Artittaya Athipanyasilp, Krittapas Jantarug, Niracha Athipanyasilp und 21 weitere

The CRISPR Journal · 01.04.2023 · 6 (2) · 99-115

DOI: 10.1089/crispr.2022.0048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The CRISPR Journal, online erschienen am 13.04.2023. Verfasst von Maturada Patchsung und 32 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomolecular Science and Engineering, Vidyasirimedhi Institute of Science and Technology (VISTEC), Rayong, Thailand. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Point-of-care (POC) nucleic acid detection technologies are poised to aid gold-standard technologies in controlling the COVID-19 pandemic, yet shortcomings in the capability to perform critically needed complex detection—such as multiplexed detection for viral variant surveillance—may limit their widespread adoption. Herein, we developed a robust multiplexed clustered regularly interspaced short palindromic repeats (CRISPR)-based detection using LwaCas13a and PsmCas13b to simultaneously diagnose severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and pinpoint the causative SARS-CoV-2 variant of concern (VOC)—including globally dominant VOCs Delta (B.1.617.2) and Omicron (B.1.1.529)—all the while maintaining high levels of accuracy upon the detection of multiple SARS-CoV-2 gene targets. The platform has several attributes suitable for POC use: premixed, freeze-dried reagents for easy use and storage; convenient direct-to-eye or smartphone-based readouts; and a one-pot variant of the multiplexed detection. To reduce reliance on proprietary reagents and enable sustainable use of such a technology in low- and middle-income countries, we locally produced and formulated our own recombinase polymerase amplification reaction and demonstrated its equivalent efficiency to commercial counterparts. Our tool—CRISPR-based detection for simultaneous COVID-19 diagnosis and variant surveillance that can be locally manufactured—may enable sustainable use of CRISPR diagnostics technologies for COVID-19 and other diseases in POC settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansCOVID-19 TestingPandemicsPoint-of-Care SystemsCRISPR-Cas SystemsGene Editing

Autor:innen und Institutionen

  • School of Biomolecular Science and Engineering, Vidyasirimedhi Institute of Science and Technology (VISTEC), Rayong, Thailand.
  • Department of Biochemistry and Center for Excellence in Protein and Enzyme Technology, Faculty of Science, Mahidol University, Bangkok, Thailand.
  • Division of Genomic Medicine and Innovation Support, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand.
  • Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • PTT Public Company Limited, Bangkok, Thailand.
  • Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Supapat Visanpattanasin, Michael A Crone, Omar Abudayyeh, Feng Zhang, Chayasith Uttamapinant

Förderung

  • Wellcome Trust
  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Patchsung, M., Homchan, A., Aphicho, K., Suraritdechachai, S., Wanitchanon, T., Pattama, A., Sappakhaw, K., Meesawat, P., Wongsatit, T., Athipanyasilp, A., Jantarug, K., Athipanyasilp, N., Buahom, J., Visanpattanasin, S., Niljianskul, N., Chaiyen, P., Tinikul, R., Wichukchinda, N., Mahasirimongkol, S., …, & Uttamapinant, C. (2023). A Multiplexed Cas13-Based Assay with Point-of-Care Attributes for Simultaneous COVID-19 Diagnosis and Variant Surveillance. The CRISPR Journal, 6(2), 99-115. https://doi.org/10.1089/crispr.2022.0048

Vancouver

Patchsung M, Homchan A, Aphicho K, Suraritdechachai S, Wanitchanon T, Pattama A, et al. A Multiplexed Cas13-Based Assay with Point-of-Care Attributes for Simultaneous COVID-19 Diagnosis and Variant Surveillance. The CRISPR Journal. 2023;6(2):99-115. doi:10.1089/crispr.2022.0048

BibTeX
@article{Patchsung2023,
  author = {Patchsung, Maturada and Homchan, Aimorn and Aphicho, Kanokpol and Suraritdechachai, Surased and Wanitchanon, Thanyapat and Pattama, Archiraya and Sappakhaw, Khomkrit and Meesawat, Piyachat and Wongsatit, Thanakrit and Athipanyasilp, Artittaya and Jantarug, Krittapas and Athipanyasilp, Niracha and Buahom, Juthamas and Visanpattanasin, Supapat and Niljianskul, Nootaree and Chaiyen, Pimchai and Tinikul, Ruchanok and Wichukchinda, Nuanjun and Mahasirimongkol, Surakameth and Sirijatuphat, Rujipas and Angkasekwinai, Nasikarn and Crone, Michael A and Freemont, Paul S and Joung, Julia and Ladha, Alim and Abudayyeh, Omar and Gootenberg, Jonathan and Zhang, Feng and Chewapreecha, Claire and Chanarat, Sittinan and Horthongkham, Navin and Pakotiprapha, Danaya and Uttamapinant, Chayasith},
  title = {A Multiplexed Cas13-Based Assay with Point-of-Care Attributes for Simultaneous COVID-19 Diagnosis and Variant Surveillance},
  journal = {The CRISPR Journal},
  year = {2023},
  volume = {6},
  number = {2},
  pages = {99--115},
  doi = {10.1089/crispr.2022.0048}
}
Kostenlos starten →